{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:45:39Z","timestamp":1790642739226,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T00:00:00Z","timestamp":1764374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hum Genomics"],"DOI":"10.1186\/s40246-025-00853-3","type":"journal-article","created":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T20:06:50Z","timestamp":1764446810000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Functional analysis of BRCA1 and BRCA2 splicing variants using a minigene assay"],"prefix":"10.1186","volume":"20","author":[{"given":"Hara","family":"Yim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seonhoo","family":"Youn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Won","family":"Chae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeseul","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joowon","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Im","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jee-Soo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moon-woo","family":"Seong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,29]]},"reference":[{"issue":"2","key":"853_CR1","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s10549-009-0348-7","volume":"118","author":"R Yang","year":"2009","unstructured":"Yang R, Chen B, Hemminki K, Wappenschmidt B, Engel C, Sutter C, et al. Polymorphisms in BRCA2 resulting in aberrant codon-usage and their analysis on Familial breast cancer risk. Breast Cancer Res Treat. 2009;118(2):407\u201313. https:\/\/doi.org\/10.1007\/s10549-009-0348-7. PMID:19229607.","journal-title":"Breast Cancer Res Treat"},{"key":"853_CR2","doi-asserted-by":"crossref","unstructured":"Rosen EM, Pishvaian MJ. Targeting the BRCA1\/2 tumor suppressors. Curr Drug Targets. 2014 Jan. PMID:24387337.","DOI":"10.2174\/1389450114666140106095432"},{"key":"853_CR3","doi-asserted-by":"publisher","unstructured":"Siegel RL, Giaquinto AN, Jemal A, Cancer statistics, Cancer JC. 2024 Jan-Feb;74(1):12\u201349. https:\/\/doi.org\/10.3322\/caac.21820. PMID:38230766.","DOI":"10.3322\/caac.21820"},{"key":"853_CR4","doi-asserted-by":"publisher","unstructured":"Apostolou P, Fostira F. Hereditary breast cancer: the era of new susceptibility genes. Biomed Res Int. 2013;2013:747318. https:\/\/doi.org\/10.1155\/2013\/747318. PMID:23586058.","DOI":"10.1155\/2013\/747318"},{"key":"853_CR5","doi-asserted-by":"publisher","unstructured":"Yang S, Green A, Brown N, Robinson A, Senat M, Testino B et al. Sustained delivery of PARP inhibitor Talazoparib for the treatment of BRCA-deficient ovarian cancer. Front Oncol. 2023;13:1175617. https:\/\/doi.org\/10.3389\/fonc.2023.1175617. PMID:37228496.","DOI":"10.3389\/fonc.2023.1175617"},{"issue":"12","key":"853_CR6","doi-asserted-by":"publisher","first-page":"524","DOI":"10.3390\/cancers10120524","volume":"10","author":"J Kotsopoulos","year":"2018","unstructured":"Kotsopoulos J. BRCA mutations and breast cancer prevention. Cancers (Basel). 2018;10(12):524. https:\/\/doi.org\/10.3390\/cancers10120524. PMID:30572612.","journal-title":"Cancers (Basel)"},{"key":"853_CR7","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/aja.2011.150","volume":"14","author":"E Castro","year":"2012","unstructured":"Castro E, Eeles R. The role of BRCA1 and BRCA2 in prostate cancer. Asian J Androl. 2012;14:409\u201314.","journal-title":"Asian J Androl"},{"issue":"23","key":"853_CR8","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1001\/jama.2017.7112","volume":"317","author":"KB Kuchenbaecker","year":"2017","unstructured":"Kuchenbaecker KB, Hopper JL, Barnes DR, et al. Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA. 2017;317(23):2402\u201316. https:\/\/doi.org\/10.1001\/jama.2017.7112.","journal-title":"JAMA"},{"key":"853_CR9","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12575-020-00133-5","volume":"22","author":"F Sadeghi","year":"2020","unstructured":"Sadeghi F, Asgari M, Matloubi M, et al. Molecular contribution of BRCA1 and BRCA2 to genome instability in breast cancer patients: review of radiosensitivity assays. Biol Proced Online. 2020;22:23. https:\/\/doi.org\/10.1186\/s12575-020-00133-5.","journal-title":"Biol Proced Online"},{"key":"853_CR10","doi-asserted-by":"publisher","unstructured":"Walsh CS. Two decades beyond BRCA1\/2: homologous recombination, hereditary cancer risk and a target for ovarian cancer therapy. Gynecol Oncol. 2015;137(2):343\u201350. https:\/\/doi.org\/10.1016\/j.ygyno.2015.02.017","DOI":"10.1016\/j.ygyno.2015.02.017"},{"issue":"5","key":"853_CR11","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1093\/nar\/gkl010","volume":"34","author":"CX Deng","year":"2006","unstructured":"Deng CX. BRCA1: cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution. Nucleic Acids Res. 2006;34(5):1416\u201326. https:\/\/doi.org\/10.1093\/nar\/gkl010. PMID:16522651.","journal-title":"Nucleic Acids Res"},{"key":"853_CR12","doi-asserted-by":"publisher","unstructured":"Godet I, Gilkes DM. BRCA1 and BRCA2 mutations and treatment strategies for breast cancer. Integr Cancer Sci Ther. 2017;4(1). https:\/\/doi.org\/10.15761\/ICST.1000228. PMID:28706734.","DOI":"10.15761\/ICST.1000228"},{"issue":"5","key":"853_CR13","doi-asserted-by":"publisher","first-page":"4982","DOI":"10.3390\/ijms24054982","volume":"24","author":"AP Loboda","year":"2023","unstructured":"Loboda AP, Adonin LS, Zvereva SD, et al. BRCA mutations\u2014the Achilles heel of breast, ovarian and other epithelial cancers. Int J Mol Sci. 2023;24(5):4982. https:\/\/doi.org\/10.3390\/ijms24054982. PMID:36902416.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"853_CR14","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1093\/hmg\/10.7.705","volume":"10","author":"PL Welcsh","year":"2001","unstructured":"Welcsh PL, King MC. BRCA1 and BRCA2 and the genetics of breast and ovarian cancer. Hum Mol Genet. 2001;10(7):705\u201313. https:\/\/doi.org\/10.1093\/hmg\/10.7.705.","journal-title":"Hum Mol Genet"},{"key":"853_CR15","doi-asserted-by":"publisher","unstructured":"Weisschuh N, Buena-Atienza E, Wissinger B. Splicing mutations in inherited retinal diseases. Prog Retin Eye Res. 2021;80:100874. https:\/\/doi.org\/10.1016\/j.preteyeres.2020.100874. PMID:32553897.","DOI":"10.1016\/j.preteyeres.2020.100874"},{"issue":"5","key":"853_CR16","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1634\/theoncologist.2012-0452","volume":"18","author":"NM Lindor","year":"2013","unstructured":"Lindor NM, Goldgar DE, Tavtigian SV, et al. BRCA1\/2 sequence variants of uncertain significance: a primer for providers to assist in discussions and in medical management. Oncologist. 2013;18(5):518\u201324. https:\/\/doi.org\/10.1634\/theoncologist.2012-0452. PMID:23615697.","journal-title":"Oncologist"},{"issue":"2","key":"853_CR17","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s00432-023-05597-y","volume":"150","author":"Y Ning","year":"2024","unstructured":"Ning Y, Zhang Y, Tian T, et al. Reclassifying BRCA1 c.4358-2A\u2009>\u2009G and BRCA2 c.475\u2009+\u20095G\u2009>\u2009C variants from \u2018uncertain significance\u2019 to \u2018pathogenic\u2019 based on minigene assays and clinical evidence. J Cancer Res Clin Oncol. 2024;150(2):62. https:\/\/doi.org\/10.1007\/s00432-023-05597-y. PMID:38300310.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"9","key":"853_CR18","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1016\/j.ajhg.2024.07.013","volume":"111","author":"MT Parsons","year":"2024","unstructured":"Parsons MT, de la Hoya M, Richardson ME, et al. Evidence-based recommendations for gene-specific ACMG\/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 variant curation expert panel. Am J Hum Genet. 2024;111(9):2044\u201358. https:\/\/doi.org\/10.1016\/j.ajhg.2024.07.013. Epub 2024 Aug 13. PMID:39142283; PMCID:PMC11393667.","journal-title":"Am J Hum Genet"},{"key":"853_CR19","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40246-023-00451-1","volume":"17","author":"JM de Sainte Agathe","year":"2023","unstructured":"de Sainte Agathe JM, Filser M, Isidor B, et al. SpliceAI-visual: a free online tool to improve spliceai splicing variant interpretation. Hum Genomics. 2023;17:7. https:\/\/doi.org\/10.1186\/s40246-023-00451-1.","journal-title":"Hum Genomics"},{"issue":"9","key":"853_CR20","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1093\/bioinformatics\/btu031","volume":"30","author":"P Jones","year":"2014","unstructured":"Jones P, Binns D, Chang HY, et al. InterProScan 5: genome-scale protein function classification. Bioinformatics. 2014;30(9):1236\u201340. https:\/\/doi.org\/10.1093\/bioinformatics\/btu031.","journal-title":"Bioinformatics"},{"key":"853_CR21","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13059-016-0974-4","volume":"17","author":"W McLaren","year":"2016","unstructured":"McLaren W, Gil L, Hunt SE, Riat HS, Ritchie GR, Thormann A, et al. The ensembl variant effect predictor. Genome Biol. 2016;17:122. https:\/\/doi.org\/10.1186\/s13059-016-0974-4.","journal-title":"Genome Biol"},{"issue":"8016","key":"853_CR22","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","volume":"630","author":"J Abramson","year":"2024","unstructured":"Abramson J, Adler J, Dunger J, et al. Accurate structure prediction of biomolecular interactions with alphafold 3. Nature. 2024;630(8016):493\u2013500. https:\/\/doi.org\/10.1038\/s41586-024-07487-w. PMID:38718835.","journal-title":"Nature"},{"issue":"15","key":"853_CR23","doi-asserted-by":"publisher","first-page":"e2016239118","DOI":"10.1073\/pnas.2016239118","volume":"118","author":"A Rives","year":"2021","unstructured":"Rives A, Meier J, Sercu T, Goyal S, Lin Z, Liu J, et al. Biological structure and function emerge from scaling unsupervised learning to 250 million protein sequences. *Proc Natl Acad Sci U S A*. 2021;118(15):e2016239118. https:\/\/doi.org\/10.1073\/pnas.2016239118. PMID:33753512.","journal-title":"*Proc Natl Acad Sci U S A*"},{"key":"853_CR24","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/s41588-022-01293-8","volume":"55","author":"R Dawes","year":"2023","unstructured":"Dawes R, Bournazos AM, Bryen SJ, et al. SpliceVault predicts the precise nature of variant-associated mis-splicing. Nat Genet. 2023;55:324\u201332. https:\/\/doi.org\/10.1038\/s41588-022-01293-8.","journal-title":"Nat Genet"},{"key":"853_CR25","doi-asserted-by":"publisher","unstructured":"Fraile-Bethencourt E, Valenzuela-Palomo A, D\u00edez-G\u00f3mez B et al. Minigene splicing assays identify 12 spliceogenic variants of BRCA2 exons 14 and 15. Front Genet. 2019;10:503. https:\/\/doi.org\/10.3389\/fgene.2019.00503. PMID:31191615.","DOI":"10.3389\/fgene.2019.00503"},{"issue":"2","key":"853_CR26","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3390\/genes13020268","volume":"13","author":"TNN Le","year":"2022","unstructured":"Le TNN, Tran VK, Nguyen TT, et al. BRCA1\/2 mutations in Vietnamese patients with hereditary breast and ovarian cancer syndrome. Genes (Basel). 2022;13(2):268. https:\/\/doi.org\/10.3390\/genes13020268.","journal-title":"Genes (Basel)"},{"issue":"5588","key":"853_CR27","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1126\/science.297.5588.1837","volume":"297","author":"H Yang","year":"2002","unstructured":"Yang H, Li Q, Fan J, et al. BRCA2 function in DNA binding and recombination from a BRCA2-DSS1-ssDNA structure. Science. 2002;297(5588):1837\u201348. https:\/\/doi.org\/10.1126\/science.297.5588.1837.","journal-title":"Science"},{"issue":"8","key":"853_CR28","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.3390\/genes12081229","volume":"12","author":"HP Le","year":"2021","unstructured":"Le HP, Heyer WD, Liu J. Guardians of the genome: BRCA2 and its partners. Genes (Basel). 2021;12(8):1229. https:\/\/doi.org\/10.3390\/genes12081229. PMID:34440403.","journal-title":"Genes (Basel)"},{"key":"853_CR29","doi-asserted-by":"publisher","first-page":"701652","DOI":"10.3389\/fgene.2021.701652","volume":"12","author":"JH Lin","year":"2021","unstructured":"Lin JH, Wu H, Zou WB, et al. Splicing outcomes of 5\u2019 splice site GT\u2009>\u2009GC variants that generate wild-type transcripts differ significantly between full-length and minigene splicing assays. Front Genet. 2021;12:701652. https:\/\/doi.org\/10.3389\/fgene.2021.701652. PMID:34422003; PMCID:PMC8375439.","journal-title":"Front Genet"},{"issue":"4","key":"853_CR30","doi-asserted-by":"publisher","first-page":"e2128","DOI":"10.1002\/mgg3.2128","volume":"11","author":"X Shi","year":"2023","unstructured":"Shi X, Wang H, Zhang R, et al. Minigene splicing assays reveal new insights into exonic variants of the SLC12A3 gene in Gitelman syndrome. Mol Genet Genomic Med. 2023;11(4):e2128. https:\/\/doi.org\/10.1002\/mgg3.2128. PMID:36597580; PMCID:PMC10094094.","journal-title":"Mol Genet Genomic Med"},{"issue":"10","key":"853_CR31","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.1111\/jcmm.13147","volume":"21","author":"M \u00c1lvarez-Satta","year":"2017","unstructured":"\u00c1lvarez-Satta M, Castro-S\u00e1nchez S, Pousada G, Valverde D. Functional analysis by minigene assay of putative splicing variants found in Bardet-Biedl syndrome patients. J Cell Mol Med. 2017;21(10):2268\u201375. https:\/\/doi.org\/10.1111\/jcmm.13147. PMID:28502102.","journal-title":"J Cell Mol Med"},{"issue":"5","key":"853_CR32","doi-asserted-by":"publisher","first-page":"999","DOI":"10.3390\/cancers13050999","volume":"13","author":"V Morbidoni","year":"2021","unstructured":"Morbidoni V, Baschiera E, Forzan M, et al. Hybrid minigene assay: an efficient tool to characterize mRNA splicing profiles of NF1 variants. Cancers (Basel). 2021;13(5):999. https:\/\/doi.org\/10.3390\/cancers13050999. PMID:33673681.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"853_CR33","doi-asserted-by":"publisher","first-page":"6506","DOI":"10.1038\/s41598-024-56704-z","volume":"14","author":"M Yamada","year":"2024","unstructured":"Yamada M, Maeta K, Suzuki H, et al. Successful skipping of abnormal pseudoexon by antisense oligonucleotides in vitro for a patient with beta-propeller protein-associated neurodegeneration. Sci Rep. 2024;14(1):6506. https:\/\/doi.org\/10.1038\/s41598-024-56704-z. PMID:38499569.","journal-title":"Sci Rep"},{"key":"853_CR34","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1038\/s42003-023-05513-7","volume":"6","author":"J Xie","year":"2023","unstructured":"Xie J, Wang L, Lin RJ. Variations of intronic branchpoint motif: identification and functional implications in splicing and disease. Commun Biol. 2023;6:1142. https:\/\/doi.org\/10.1038\/s42003-023-05513-7.","journal-title":"Commun Biol"},{"issue":"9","key":"853_CR35","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.3390\/genes12091308","volume":"12","author":"C Ha","year":"2021","unstructured":"Ha C, Kim JW, Jang JH. Performance evaluation of spliceai for the prediction of splicing of NF1 variants. Genes (Basel). 2021;12(9):1308. https:\/\/doi.org\/10.3390\/genes12091308. PMID:34573290.","journal-title":"Genes (Basel)"},{"key":"853_CR36","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s40246-024-00586-9","volume":"18","author":"H Wu","year":"2024","unstructured":"Wu H, Lin JH, Tang XY, et al. Combining full-length gene assay and spliceai to interpret the splicing impact of all possible SPINK1 coding variants. Hum Genomics. 2024;18:21. https:\/\/doi.org\/10.1186\/s40246-024-00586-9.","journal-title":"Hum Genomics"},{"key":"853_CR37","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41525-025-00498-0","volume":"10","author":"DM Canson","year":"2025","unstructured":"Canson DM, Llinares-Burguet I, Fortuno C, et al. TP53 minigene analysis of 161 sequence changes provides evidence for role of Spatial constraint and regulatory elements on variant-induced splicing impact. NPJ Genom Med. 2025;10:37. https:\/\/doi.org\/10.1038\/s41525-025-00498-0.","journal-title":"NPJ Genom Med"}],"container-title":["Human Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40246-025-00853-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40246-025-00853-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40246-025-00853-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T15:42:35Z","timestamp":1767627755000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40246-025-00853-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,29]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["853"],"URL":"https:\/\/doi.org\/10.1186\/s40246-025-00853-3","relation":{},"ISSN":["1479-7364"],"issn-type":[{"value":"1479-7364","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,29]]},"assertion":[{"value":"30 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approval for the use of human samples in this study was obtained from the Institutional Review Board of Seoul National University Hospital (Approval No. IRB-1102-102-357).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1"}}